Related Experiment Video
Updated: May 12, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
In vitro transformation of the tremorgenic mycotoxin verruculogen
1Institute for Medical Microbiology, Infectious and Epidemic Diseases, Veterinary Faculty, University of Munich, Veterinaerstr 13, W-8000, Munich 22, Germany.
Abstract:
A quantity of 50 mg of crystalline verruculogen was prepared from batch cultures ofAspergillus fumigatus for the use in thein vitro studies with S-9 liver fractions, feces suspensions, and cultures ofEscherichia coli.Incubation of verruculogen with S-9 liver fractions from swine resulted in the transformation of the parent compound into TR-2 toxin and 3 other more polar.TR-2 toxin was also shown to be the main transformation product when incubat-ing verruculogen with fecal suspensions or pure cultures ofE. coli (0149: K88). Incubation times of more than 2 hours led to a complete degradation of verruculogen as well as TR -2 toxin.
Related Concept Videos
In-vitro Mutagenesis
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
In vitro Mutagenesis
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Transformation

